Loading...

Lilly Bourguignon, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
AddressVAMC
San Francisco CA 94121
Phone415-221-4810 ext. 3321
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Selective Hyaluronan Treatment to Overcome Age-related Epidermal Dysfunction
    VA I01RX000601Apr 1, 2013 - Mar 31, 2017
    Role: Principal Investigator
    CD44 &Stem Cell Marker (Nanog) in Head and Neck Cancer
    VA I01BX000628Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    CD44-p185HER2 Interaction in Ovarian Cancer Progression
    NIH/NCI R01CA078633Apr 1, 1999 - Jan 31, 2010
    Role: Principal Investigator
    CD44/Variant Cytoskeleton in Breast Cancer Progression
    NIH/NCI R01CA066163Apr 1, 1995 - May 31, 2014
    Role: Principal Investigator
    BIOCHEMICAL &CYTOCHEMICAL STUDIES ON LYMPHOID MEMBRANE
    NIH/NIGMS R01GM036353Jan 1, 1982 - Jun 30, 1996
    Role: Principal Investigator
    BIOCHEMICAL AND IMMUNOCYTOCHEMICAL LYMPHOCYTE STUDIES
    NIH/NIAID R01AI019188Jan 1, 1982 - Dec 31, 1986
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bourguignon L, Earle C, Shiina M. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Int J Mol Sci. 2017 Aug 24; 18(9). PMID: 28837080.
      View in: PubMed
    2. Bourguignon L. Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression. Int J Mol Sci. 2016 Apr 07; 17(4):517. PMID: 27070574; PMCID: PMC4848973.
      View in: PubMed, PubMed Central
    3. Bourguignon L, Wong G, Shiina M. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. J Biol Chem. 2016 May 13; 291(20):10571-85. PMID: 27002147; PMCID: PMC4865907 [Available on 05/13/17].
      View in: PubMed, PubMed Central
    4. Shiina M, Bourguignon L. Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer. Int J Cell Biol. 2015; 2015:989070. PMID: 26448762; PMCID: PMC4581563.
      View in: PubMed, PubMed Central
    5. Hurst RE, Hauser PJ, You Y, Bailey-Downs LC, Bastian A, Matthews SM, Thorpe J, Earle C, Bourguignon L, Ihnat MA. Identification of novel drugs to target dormant micrometastases. BMC Cancer. 2015 May 14; 15:404. PMID: 25971923; PMCID: PMC4434572.
      View in: PubMed, PubMed Central
    6. Bourguignon L, Bikle D. Selective Hyaluronan-CD44 Signaling Promotes miRNA-21 Expression and Interacts with Vitamin D Function during Cutaneous Squamous Cell Carcinomas Progression Following UV Irradiation. Front Immunol. 2015; 6:224. PMID: 26029210; PMCID: PMC4429634.
      View in: PubMed, PubMed Central
    7. Braet Y, Bourguignon L, Vanpoucke S, Drome V, Hubrecht F. New developmental data for Cynomya mortuorum (L., 1761) in Belgium (Diptera: Calliphoridae). Forensic Sci Int. 2015 Jul; 252:29-32. PMID: 25933426.
      View in: PubMed
    8. Bourguignon L. Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions. Am J Pathol. 2014 Jul; 184(7):1912-9. PMID: 24819962; PMCID: PMC4076472.
      View in: PubMed, PubMed Central
    9. Chen L, Bourguignon L. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells. Mol Cancer. 2014 Mar 08; 13:52. PMID: 24606718; PMCID: PMC3975292.
      View in: PubMed, PubMed Central
    10. Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, Bourguignon L. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol. 2014 Mar; 132(3):739-44. PMID: 24472409.
      View in: PubMed
    11. Bourguignon L, Shiina M, Li JJ. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression. Adv Cancer Res. 2014; 123:255-75. PMID: 25081533.
      View in: PubMed
    12. Bourguignon L, Wong G, Xia W, Man MQ, Holleran WM, Elias PM. Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction. J Dermatol Sci. 2013 Oct; 72(1):32-44. PMID: 23790635.
      View in: PubMed
    13. Bourguignon L, Wong G, Earle C, Chen L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2012 Sep 21; 287(39):32800-24. PMID: 22847005; PMCID: PMC3463333.
      View in: PubMed, PubMed Central
    14. Wang SJ, Earle C, Wong G, Bourguignon L. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. Head Neck. 2013 Apr; 35(4):511-20. PMID: 22473523.
      View in: PubMed
    15. Bourguignon L. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression. Small GTPases. 2012 Jan-Mar; 3(1):53-9. PMID: 22714418; PMCID: PMC3398919.
      View in: PubMed, PubMed Central
    16. Bourguignon L, Wong G, Earle CA, Xia W. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NF?B signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken). 2011 Dec; 68(12):671-93. PMID: 22031535; PMCID: PMC3240717.
      View in: PubMed, PubMed Central
    17. Bourguignon L, Earle C, Wong G, Spevak CC, Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene. 2012 Jan 12; 31(2):149-60. PMID: 21685938; PMCID: PMC3179812.
      View in: PubMed, PubMed Central
    18. Wang SJ, Bourguignon L. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol. 2011 Mar; 178(3):956-63. PMID: 21356346; PMCID: PMC3069910.
      View in: PubMed, PubMed Central
    19. Bourguignon L, Wong G, Earle C, Krueger K, Spevak CC. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem. 2010 Nov 19; 285(47):36721-35. PMID: 20843787; PMCID: PMC2978601.
      View in: PubMed, PubMed Central
    20. Torre C, Wang SJ, Xia W, Bourguignon L. Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling. Arch Otolaryngol Head Neck Surg. 2010 May; 136(5):493-501. PMID: 20479382; PMCID: PMC2874205.
      View in: PubMed, PubMed Central
    21. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon L. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009 Aug; 119(8):1518-30. PMID: 19507218; PMCID: PMC2718060.
      View in: PubMed, PubMed Central
    22. Bourguignon L, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem. 2009 Sep 25; 284(39):26533-46. PMID: 19633292; PMCID: PMC2785342.
      View in: PubMed, PubMed Central
    23. Dekeirsschieter J, Verheggen FJ, Gohy M, Hubrecht F, Bourguignon L, Lognay G, Haubruge E. Cadaveric volatile organic compounds released by decaying pig carcasses (Sus domesticus L.) in different biotopes. Forensic Sci Int. 2009 Aug 10; 189(1-3):46-53. PMID: 19423246.
      View in: PubMed
    24. Man M, Elias PM, Man W, Wu Y, Bourguignon L, Feingold KR, Man MQ. The role of CD44 in cutaneous inflammation. Exp Dermatol. 2009 Nov; 18(11):962-8. PMID: 19469887; PMCID: PMC2784008.
      View in: PubMed, PubMed Central
    25. Hsu JY, Bourguignon L, Adams CM, Peyrollier K, Zhang H, Fandel T, Cun CL, Werb Z, Noble-Haeusslein LJ. Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci. 2008 Dec 10; 28(50):13467-77. PMID: 19074020; PMCID: PMC2712293.
      View in: PubMed, PubMed Central
    26. Bourguignon L, Xia W, Wong G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem. 2009 Jan 30; 284(5):2657-71. PMID: 19047049; PMCID: PMC2631959.
      View in: PubMed, PubMed Central
    27. Bourguignon L, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem. 2008 Jun 20; 283(25):17635-51. PMID: 18441325; PMCID: PMC2427357.
      View in: PubMed, PubMed Central
    28. Bourguignon L. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol. 2008 Aug; 18(4):251-9. PMID: 18450475; PMCID: PMC2505114.
      View in: PubMed, PubMed Central
    29. Wang SJ, Wreesmann VB, Bourguignon L. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck. 2007 Jun; 29(6):550-8. PMID: 17252589.
      View in: PubMed
    30. Bourguignon L, Gilad E, Peyrollier K. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007 Jul 06; 282(27):19426-41. PMID: 17493932.
      View in: PubMed
    31. Bourguignon L, Gilad E, Peyrollier K, Brightman A, Swanson RA. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. J Neurochem. 2007 May; 101(4):1002-17. PMID: 17403031.
      View in: PubMed
    32. Wang SJ, Peyrollier K, Bourguignon L. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2007 Mar; 133(3):281-8. PMID: 17372087.
      View in: PubMed
    33. Bourguignon L, Peyrollier K, Gilad E, Brightman A. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem. 2007 Jan 12; 282(2):1265-80. PMID: 17092940.
      View in: PubMed
    34. Wang SJ, Bourguignon L. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006 Jul; 132(7):771-8. PMID: 16847188.
      View in: PubMed
    35. Bourguignon L, Ramez M, Gilad E, Singleton PA, Man MQ, Crumrine DA, Elias PM, Feingold KR. Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis. J Invest Dermatol. 2006 Jun; 126(6):1356-65. PMID: 16557236.
      View in: PubMed
    36. Bourguignon L, Gilad E, Brightman A, Diedrich F, Singleton P. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 2006 May 19; 281(20):14026-40. PMID: 16565089.
      View in: PubMed
    37. Wang SJ, Bourguignon L. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006 Jan; 132(1):19-24. PMID: 16415424.
      View in: PubMed
    38. Xie Z, Singleton PA, Bourguignon L, Bikle DD. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell. 2005 Jul; 16(7):3236-46. PMID: 15872086; PMCID: PMC1165407.
      View in: PubMed, PubMed Central
    39. Bourguignon L, Gilad E, Rothman K, Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem. 2005 Mar 25; 280(12):11961-72. PMID: 15655247.
      View in: PubMed
    40. Cao JJ, Singleton PA, Majumdar S, Boudignon B, Burghardt A, Kurimoto P, Wronski TJ, Bourguignon L, Halloran BP. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J Bone Miner Res. 2005 Jan; 20(1):30-40. PMID: 15619667.
      View in: PubMed
    41. Bourguignon L, Singleton PA, Diedrich F. Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase Cgamma1 activation, Ca(2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation. J Biol Chem. 2004 Jul 09; 279(28):29654-69. PMID: 15123640.
      View in: PubMed
    42. Bourguignon L, Singleton PA, Diedrich F, Stern R, Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem. 2004 Jun 25; 279(26):26991-7007. PMID: 15090545.
      View in: PubMed
    43. Singleton PA, Bourguignon L. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp Cell Res. 2004 Apr 15; 295(1):102-18. PMID: 15051494.
      View in: PubMed
    44. Bourguignon L, Singleton PA, Zhu H, Diedrich F. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem. 2003 Aug 08; 278(32):29420-34. PMID: 12748184.
      View in: PubMed
    45. Singleton PA, Bourguignon L. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motil Cytoskeleton. 2002 Dec; 53(4):293-316. PMID: 12378540.
      View in: PubMed
    46. Bourguignon L, Singleton PA, Zhu H, Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem. 2002 Oct 18; 277(42):39703-12. PMID: 12145287.
      View in: PubMed
    47. Turley EA, Noble PW, Bourguignon L. Signaling properties of hyaluronan receptors. J Biol Chem. 2002 Feb 15; 277(7):4589-92. PMID: 11717317.
      View in: PubMed
    48. Bourguignon L, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem. 2001 Dec 28; 276(52):48679-92. PMID: 11606575.
      View in: PubMed
    49. Chang W, Pratt S, Chen TH, Bourguignon L, Shoback D. Amino acids in the cytoplasmic C terminus of the parathyroid Ca2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation. J Biol Chem. 2001 Nov 23; 276(47):44129-36. PMID: 11535593.
      View in: PubMed
    50. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001 Sep; 3(9):802-8. PMID: 11533659.
      View in: PubMed
    51. Bourguignon L. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001 Jul; 6(3):287-97. PMID: 11547898.
      View in: PubMed
    52. Hunter JR, Brickley MB, Bourgeois J, Bouts W, Bourguignon L, Hubrecht F, De Winne J, Van Haaster H, Hakbijl T, De Jong H, Smits L, Van Wijngaarden LH, Luschen M. Forensic archaeology, forensic anthropology and human rights in Europe. Sci Justice. 2001 Jul-Sep; 41(3):173-8. PMID: 11515163.
      View in: PubMed
    53. Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon L. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg. 2001 Apr; 124(4):426-32. PMID: 11283501.
      View in: PubMed
    54. Gofflot F, Gaoua W, Bourguignon L, Roux C, Picard JJ. Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in utero to a distal inhibitor of cholesterol biosynthesis. Dev Dyn. 2001 Feb; 220(2):99-111. PMID: 11169843.
      View in: PubMed
    55. Bourguignon L, Zhu H, Shao L, Chen YW. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem. 2001 Mar 09; 276(10):7327-36. PMID: 11084024.
      View in: PubMed
    56. Bourguignon L, Zhu H, Shao L, Chen YW. Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J Cell Biol. 2000 Jul 10; 150(1):177-91. PMID: 10893266; PMCID: PMC2185563.
      View in: PubMed, PubMed Central
    57. Diaz F, Bourguignon L. Selective down-regulation of IP(3)receptor subtypes by caspases and calpain during TNF alpha -induced apoptosis of human T-lymphoma cells. Cell Calcium. 2000 Jun; 27(6):315-28. PMID: 11013462.
      View in: PubMed
    58. Zhu D, Bourguignon L. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration. J Cell Physiol. 2000 May; 183(2):182-95. PMID: 10737894.
      View in: PubMed
    59. Bourguignon L, Zhu H, Shao L, Chen YW. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem. 2000 Jan 21; 275(3):1829-38. PMID: 10636882.
      View in: PubMed
    60. Kalish ED, Iida N, Moffat FL, Bourguignon L. A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression. Front Biosci. 1999 Jan 01; 4:A1-8. PMID: 9872731.
      View in: PubMed
    61. Bourguignon L, Zhu H, Shao L, Zhu D, Chen YW. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton. 1999; 43(4):269-87. PMID: 10423269.
      View in: PubMed
    62. Bourguignon L, Zhu D, Zhu H. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci. 1998 Jul 01; 3:d637-49. PMID: 9634539.
      View in: PubMed
    63. Bourguignon L, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998 Jul; 176(1):206-15. PMID: 9618160.
      View in: PubMed
    64. Zhu D, Bourguignon L. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motil Cytoskeleton. 1998; 39(3):209-22. PMID: 9519902.
      View in: PubMed
    65. Huang AJ, Li CH, Chen YW, Bourguignon L. Co-expression of bcl-2 and CD44s in basal layers of human ocular surface epithelia. Adv Exp Med Biol. 1998; 438:527-31. PMID: 9634932.
      View in: PubMed
    66. Bourguignon L, Zhu H, Chu A, Iida N, Zhang L, Hung MC. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem. 1997 Oct 31; 272(44):27913-8. PMID: 9346940.
      View in: PubMed
    67. Iida N, Bourguignon L. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis. J Cell Physiol. 1997 May; 171(2):152-60. PMID: 9130462.
      View in: PubMed
    68. Lokeshwar VB, Iida N, Bourguignon L. The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J Biol Chem. 1996 Sep 27; 271(39):23853-64. PMID: 8798616.
      View in: PubMed
    69. Moffat FL, Han T, Li ZM, Peck MD, Falk RE, Spalding PB, Jy W, Ahn YS, Chu AJ, Bourguignon L. Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J Cell Physiol. 1996 Sep; 168(3):638-47. PMID: 8816918.
      View in: PubMed
    70. Peck MD, Li Z, Han T, Wang W, Jy W, Ahn YS, Ziboh VA, Chu AJ, Bourguignon L. Fatty acid unsaturation increases expression and capping of murine lymphocyte CD44 and CD45. Nutrition. 1996 Sep; 12(9):616-22. PMID: 8878171.
      View in: PubMed
    71. Peck MD, Li Z, Jy W, Chu AJ, Bourguignon L. Association of murine splenocyte CD3 complex to the cytoskeleton: absence of modulation by exogenous fatty acids. Cell Biol Int. 1996 Aug; 20(8):531-7. PMID: 8938986.
      View in: PubMed
    72. Donnadieu E, Bourguignon L. Ca2+ signaling in endothelial cells stimulated by bradykinin: Ca2+ measurement in the mitochondria and the cytosol by confocal microscopy. Cell Calcium. 1996 Jul; 20(1):53-61. PMID: 8864571.
      View in: PubMed
    73. Moffat FL, Han T, Li ZM, Peck MD, Jy W, Ahn YS, Chu AJ, Bourguignon L. Supplemental L-arginine HCl augments bacterial phagocytosis in human polymorphonuclear leukocytes. J Cell Physiol. 1996 Jul; 168(1):26-33. PMID: 8647919.
      View in: PubMed
    74. Zhu D, Bourguignon L. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Oncogene. 1996 Jun 06; 12(11):2309-14. PMID: 8649770.
      View in: PubMed
    75. Welsh CF, Zhu D, Bourguignon L. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J Cell Physiol. 1995 Sep; 164(3):605-12. PMID: 7544357.
      View in: PubMed
    76. Bourguignon L, Chu A, Jin H, Brandt NR. Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. J Biol Chem. 1995 Jul 28; 270(30):17917-22. PMID: 7629097.
      View in: PubMed
    77. Bourguignon L, Jin H. Identification of the ankyrin-binding domain of the mouse T-lymphoma cell inositol 1,4,5-trisphosphate (IP3) receptor and its role in the regulation of IP3-mediated internal Ca2+ release. J Biol Chem. 1995 Mar 31; 270(13):7257-60. PMID: 7706265.
      View in: PubMed
    78. Iida N, Bourguignon L. New CD44 splice variants associated with human breast cancers. J Cell Physiol. 1995 Jan; 162(1):127-33. PMID: 7529235.
      View in: PubMed
    79. Iida N, Lokeshwar VB, Bourguignon L. Mapping the fodrin binding domain in CD45, a leukocyte membrane-associated tyrosine phosphatase. J Biol Chem. 1994 Nov 18; 269(46):28576-83. PMID: 7961804.
      View in: PubMed
    80. Lokeshwar VB, Fregien N, Bourguignon L. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol. 1994 Aug; 126(4):1099-109. PMID: 7519619; PMCID: PMC2120123.
      View in: PubMed, PubMed Central
    81. Iida N, Bourguignon L. A new splice variant of the inositol-1,4,5-triphosphate (IP3) receptor. Cell Signal. 1994 May; 6(4):449-55. PMID: 7946968.
      View in: PubMed
    82. Bourguignon LY, Iida N, Sobrin L, Bourguignon L. Identification of an IP3 receptor in endothelial cells. J Cell Physiol. 1994 Apr; 159(1):29-34. PMID: 8138588.
      View in: PubMed
    83. Bourguignon L, Lokeshwar VB, Chen X, Kerrick WG. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol. 1993 Dec 15; 151(12):6634-44. PMID: 7505012.
      View in: PubMed
    84. Bourguignon L, Iida N, Jin H. The involvement of the cytoskeleton in regulating IP3 receptor-mediated internal Ca2+ release in human blood platelets. Cell Biol Int. 1993 Aug; 17(8):751-8. PMID: 8220303.
      View in: PubMed
    85. Bourguignon L, Jin H, Iida N, Brandt NR, Zhang SH. The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. J Biol Chem. 1993 Apr 05; 268(10):7290-7. PMID: 8385102.
      View in: PubMed
    86. Lokeshwar VB, Bourguignon L. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J Biol Chem. 1992 Nov 05; 267(31):22073-8. PMID: 1429559.
      View in: PubMed
    87. Lokeshwar VB, Bourguignon L. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J Biol Chem. 1992 Oct 25; 267(30):21551-7. PMID: 1400466.
      View in: PubMed
    88. Bourguignon LY, Lokeshwar VB, He J, Chen X, Bourguignon L. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol. 1992 Oct; 12(10):4464-71. PMID: 1406635; PMCID: PMC360371.
      View in: PubMed, PubMed Central
    89. Lokeshwar VB, Bourguignon L. The involvement of Ca2+ and myosin light chain kinase in collagen-induced platelet activation. Cell Biol Int Rep. 1992 Sep; 16(9):883-97. PMID: 1423657.
      View in: PubMed
    90. Lokeshwar VB, Bourguignon L. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem. 1991 Sep 25; 266(27):17983-9. PMID: 1833390.
      View in: PubMed
    91. Bourguignon L, Kalomiris EL, Lokeshwar VB. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J Biol Chem. 1991 Jun 25; 266(18):11761-5. PMID: 1828806.
      View in: PubMed
    92. Walker G, Bourguignon L. Membrane-associated 41-kDa GTP-binding protein in collagen-induced platelet activation. FASEB J. 1990 Aug; 4(11):2925-33. PMID: 2116341.
      View in: PubMed
    93. Bourguignon L, Walker G, Huang HS. Interactions between a lymphoma membrane-associated guanosine 5'-triphosphate-binding protein and the cytoskeleton during receptor patching and capping. J Immunol. 1990 Mar 15; 144(6):2242-52. PMID: 1968926.
      View in: PubMed
    94. Jy W, Fregien N, Bourguignon GJ, Bourguignon L. Role of Ca2+ in the regulation of hormone receptor exposure during lymphocyte activation. Biochim Biophys Acta. 1989 Aug 07; 983(2):153-60. PMID: 2503037.
      View in: PubMed
    95. Bourguignon GJ, Jy W, Bourguignon L. Electric stimulation of human fibroblasts causes an increase in Ca2+ influx and the exposure of additional insulin receptors. J Cell Physiol. 1989 Aug; 140(2):379-85. PMID: 2663886.
      View in: PubMed
    96. Kalomiris EL, Bourguignon L. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J Biol Chem. 1989 May 15; 264(14):8113-9. PMID: 2470741.
      View in: PubMed
    97. Walker G, Kerrick WG, Bourguignon L. The role of caldesmon in the regulation of receptor capping in mouse T-lymphoma cell. J Biol Chem. 1989 Jan 05; 264(1):496-500. PMID: 2909534.
      View in: PubMed
    98. Lopez DM, Blomberg BB, Padmanabhan RR, Bourguignon L. Nuclear disintegration of target cells by killer B lymphocytes from tumor-bearing mice. FASEB J. 1989 Jan; 3(1):37-43. PMID: 2783411.
      View in: PubMed
    99. Majercik MH, Bourguignon L. Insulin-induced myosin light-chain phosphorylation during receptor capping in IM-9 human B-lymphoblasts. Biochem J. 1988 Jun 15; 252(3):815-23. PMID: 3048249; PMCID: PMC1149220.
      View in: PubMed, PubMed Central
    100. Bourguignon LY, Jy W, Majercik MH, Bourguignon L. Lymphocyte activation and capping of hormone receptors. J Cell Biochem. 1988 Jun; 37(2):131-50. PMID: 3135294.
      View in: PubMed
    101. Maurer DR, Majercik MH, Bourguignon L. Effect of cyclic AMP on human blood platelets: induction of pseudopod formation and protein phosphorylation. Cell Biol Int Rep. 1988 Apr; 12(4):271-88. PMID: 2841028.
      View in: PubMed
    102. Kalomiris EL, Bourguignon L. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol. 1988 Feb; 106(2):319-27. PMID: 2963010; PMCID: PMC2114978.
      View in: PubMed, PubMed Central
    103. Suchard SJ, Lo HK, Bourguignon L. Isolation of Thy-1 caps and analysis of their phospholipid composition in mouse T-lymphoma cells. J Cell Physiol. 1988 Jan; 134(1):67-77. PMID: 2826503.
      View in: PubMed
    104. Bourguignon GJ, Bourguignon L. Electric stimulation of protein and DNA synthesis in human fibroblasts. FASEB J. 1987 Nov; 1(5):398-402. PMID: 3678699.
      View in: PubMed
    105. Suchard SJ, Bourguignon L. Further characterization of a fodrin-containing transmembrane complex from mouse T-lymphoma cells. Biochim Biophys Acta. 1987 Jan 09; 896(1):35-46. PMID: 3491628.
      View in: PubMed
    106. Bourguignon L, Suchard SJ, Kalomiris EL. Lymphoma Thy-1 glycoprotein is linked to the cytoskeleton via a 4.1-like protein. J Cell Biol. 1986 Dec; 103(6 Pt 1):2529-40. PMID: 2877998; PMCID: PMC2114603.
      View in: PubMed, PubMed Central
    107. Bourguignon L, Walker G, Suchard SJ, Balazovich K. A lymphoma plasma membrane-associated protein with ankyrin-like properties. J Cell Biol. 1986 Jun; 102(6):2115-24. PMID: 2940251; PMCID: PMC2114262.
      View in: PubMed, PubMed Central
    108. Bourguignon L, Balazovich K, Suchard SJ, Hindsgaul O, Pierce M. Endocytosis of mannose-6-phosphate binding sites by mouse T-lymphoma cells. J Cell Physiol. 1986 Apr; 127(1):146-61. PMID: 2870071.
      View in: PubMed
    109. Bourguignon LY, Walker G, Bourguignon L. Phorbol ester-induced phosphorylation of a transmembrane glycoprotein (GP 180) in human blood platelets. J Biol Chem. 1985 Sep 25; 260(21):11775-80. PMID: 4044578.
      View in: PubMed
    110. Majercik MH, Bourguignon L. Insulin receptor capping and its correlation with calmodulin-dependent myosin light chain kinase. J Cell Physiol. 1985 Sep; 124(3):403-10. PMID: 2931441.
      View in: PubMed
    111. Bourguignon L, Suchard SJ, Nagpal ML, Glenney JR. A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin. J Cell Biol. 1985 Aug; 101(2):477-87. PMID: 3874872; PMCID: PMC2113658.
      View in: PubMed, PubMed Central
    112. Bourguignon LY, Field S, Bourguignon L. Phosphorylation of a tropomyosin-like (30 KD) protein during platelet activation. J Cell Biochem. 1985; 29(1):19-30. PMID: 4055920.
      View in: PubMed
    113. Balazovich KJ, Lopez DM, Bourguignon L. The involvement of the cytoskeleton during antibody-dependent cellular cytotoxicity (ADCC). Cell Biol Int Rep. 1984 Nov; 8(11):923-38. PMID: 6542457.
      View in: PubMed
    114. Krishan A, Bourguignon L. Cell cycle related phenothiazine effects on adriamycin transport. Cell Biol Int Rep. 1984 Jun; 8(6):449-56. PMID: 6744425.
      View in: PubMed
    115. Bourguignon LY, Bourguignon L. Capping and the cytoskeleton. Int Rev Cytol. 1984; 87:195-224. PMID: 6325363.
      View in: PubMed
    116. Kerrick WG, Bourguignon L. Regulation of receptor capping in mouse lymphoma T cells by Ca2+-activated myosin light chain kinase. Proc Natl Acad Sci U S A. 1984 Jan; 81(1):165-9. PMID: 6582474; PMCID: PMC344631.
      View in: PubMed, PubMed Central
    117. Bourguignon L. Receptor capping in platelet membranes. Cell Biol Int Rep. 1984 Jan; 8(1):19-26. PMID: 6705052.
      View in: PubMed
    118. Howard JM, Eckert BS, Bourguignon L. Comparison of cytoskeletal organization in canine distemper virus-infected and uninfected cells. J Gen Virol. 1983 Nov; 64 (Pt 11):2379-85. PMID: 6358405.
      View in: PubMed
    119. Bourguignon L, Rubin RW, Krishan A. Cell cycle dependent receptor capping in mouse leukemic cells. Cell Biol Int Rep. 1983 Feb; 7(2):109-19. PMID: 6340839.
      View in: PubMed
    120. Bourguignon L, Hsing YC. The participation of adenylate cyclase in lymphocyte capping. Biochim Biophys Acta. 1983 Feb; 728(2):186-90. PMID: 6131691.
      View in: PubMed
    121. Bourguignon L, Kerrick WG. Receptor capping in mouse T-lymphoma cells: a Ca2+ and calmodulin-stimulated ATP-dependent process. J Membr Biol. 1983; 75(1):65-72. PMID: 6604166.
      View in: PubMed
    122. Bourguignon L, Pressman BC. Stimulation of lymphocyte receptor capping by the ionophore monensin. J Membr Biol. 1983; 73(1):91-3. PMID: 6134837.
      View in: PubMed
    123. Bourguignon L, Nagpal ML, Balazovich K, Guerriero V, Means AR. Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex. J Cell Biol. 1982 Dec; 95(3):793-7. PMID: 6984047; PMCID: PMC2112919.
      View in: PubMed, PubMed Central
    124. Bourguignon L, Balazovich K, Trowbridge IS, Hyman R. Immunoelectron microscopic localization of Thy-1 glycoprotein in wild type and Thy-1-negative lymphoma cells. Cell Biol Int Rep. 1982 Aug; 6(8):745-55. PMID: 6127167.
      View in: PubMed
    125. Bourguignon L, Butman BT. Morphological analysis of surface immunoglobulin biosynthesis in mouse B lymphoid cells using immunoelectron microscopy. Cell Immunol. 1982 Jul 15; 71(1):27-43. PMID: 6183010.
      View in: PubMed
    126. Bourguignon L, Butman BT. Intracellular localization of certain membrane glycoproteins in mouse T-lymphoma cells using immunoferritin staining of ultrathin frozen sections. J Cell Physiol. 1982 Feb; 110(2):203-12. PMID: 6121821.
      View in: PubMed
    127. Bourguignon L, Nagpal ML, Hsing YC. Phosphorylation of myosin light chain during capping of mouse T-lymphoma cells. J Cell Biol. 1981 Dec; 91(3 Pt 1):889-94. PMID: 6976966; PMCID: PMC2112802.
      View in: PubMed, PubMed Central
    128. Bourguignon GJ, Bourguignon L. Isolation and initial characterization of a lymphocyte cap structure. Biochim Biophys Acta. 1981 Aug 06; 646(1):109-18. PMID: 6268160.
      View in: PubMed
    129. Bourguignon LY, Bourguignon L. Immunocytochemical localization of intermediate filament proteins during lymphocyte capping. Cell Biol Int Rep. 1981 Aug; 5(8):783-9. PMID: 7026056.
      View in: PubMed
    130. Butman BT, Jacobsen T, Cabatu OG, Bourguignon L. The involvement of cAMP in lymphocyte capping. Cell Immunol. 1981 Jul 01; 61(2):397-403. PMID: 6265104.
      View in: PubMed
    131. Rader RL, Bourguignon L. The capping of liposomes on the surface of murine lymphoid and leukemic cells. Cell Mol Biol Incl Cyto Enzymol. 1981; 27(2-3):215-21. PMID: 7197586.
      View in: PubMed
    132. Bourguignon L, Balazovich K. Effect of the antidepressant drug-Stelazine on lymphocyte capping. Cell Biol Int Rep. 1980 Oct; 4(10):947-52. PMID: 6968248.
      View in: PubMed
    133. Butman BT, Bourguignon GJ, Bourguignon L. Lymphocyte capping induced by polycationized ferritin. J Cell Physiol. 1980 Oct; 105(1):7-15. PMID: 6253511.
      View in: PubMed
    134. Bourguignon L. Simultaneous localization of intracellular myosin and surface concanavalin A receptor clusters using immuno-electron microscopy. Cell Biol Int Rep. 1980 Jun; 4(6):541-7. PMID: 6994897.
      View in: PubMed
    135. Bourguignon L, Rozek RJ. Capping of concanavalin A receptors and their association with microfilaments in monolayer grown human fibroblastoid cells. Cell Tissue Res. 1980; 205(1):77-84. PMID: 7189138.
      View in: PubMed
    136. Bourguignon L. Biochemical analysis of ligand-induced receptor patching and capping using a novel immunolactoperoxidase iodination technique. J Cell Biol. 1979 Dec; 83(3):649-56. PMID: 391811; PMCID: PMC2110510.
      View in: PubMed, PubMed Central
    137. Bourguignon L, Rader RL, McMahon JT. Rapid separation of mouse T and B lymphocytes using wheat germ agglutinin. J Cell Physiol. 1979 Apr; 99(1):95-9. PMID: 313400.
      View in: PubMed
    138. Bourguignon L, Tokuyasu KT, Singer SJ. The capping of lymphocytes and other cells, studied by an improved method for immunofluorescence staining of frozen sections. J Cell Physiol. 1978 Jun; 95(3):239-57. PMID: 77276.
      View in: PubMed
    139. Bourguignon L, Hyman R, Trowbridge I, Singer SJ. Localization of T25 glycoprotein in wild-type and Thy 1- mutant cells by immunofluorescence and immunoelectron microscopy. J Exp Med. 1978 May 01; 147(5):1348-54. PMID: 77306; PMCID: PMC2184277.
      View in: PubMed, PubMed Central
    140. Bourguignon L, Hyman R, Trowbridge I, Singer SJ. Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies. Proc Natl Acad Sci U S A. 1978 May; 75(5):2406-10. PMID: 307764; PMCID: PMC392562.
      View in: PubMed, PubMed Central
    141. Bourguignon L, Katz ER. Isolation and characterization of the RNA of membrane-bound ribosomes in Dictyostelium discoideum. J Gen Microbiol. 1978 May; 106(1):93-101. PMID: 565802.
      View in: PubMed
    142. Singer SJ, Ash JF, Bourguignon L, Heggeness MH, Louvard D. Transmembrane interactions and the mechanisms of transport of proteins across membranes. J Supramol Struct. 1978; 9(3):373-89. PMID: 748682.
      View in: PubMed
    143. Bourguignon L, Singer SJ. Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands. Proc Natl Acad Sci U S A. 1977 Nov; 74(11):5031-5. PMID: 337308; PMCID: PMC432092.
      View in: PubMed, PubMed Central
    144. Bourguignon L, Palade GE. Incorporation of polypeptides into thylakoid membranes of Chlamydomonas reinhardtii. Cyclic variations. J Cell Biol. 1976 May; 69(2):327-44. PMID: 1262393; PMCID: PMC2109681.
      View in: PubMed, PubMed Central
    145. Katz ER, Bourguignon L. The cell cycle and its relationship to aggregation in the cellular slime mold, Dictyostelium discoideum. Dev Biol. 1974 Jan; 36(1):82-7. PMID: 4856682.
      View in: PubMed
    Lilly's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (603) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (12) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP